Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Acepodia Biotech, Inc.
Fate Therapeutics
Fate Therapeutics
Corregene Biotechnology Co., Ltd
Mie University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mie University
Herlev Hospital